Although high dietary fiber intake has been associated with a lower risk of colorectal cancer (CRC), it remains unknown whether fiber benefits CRC survivors.
C olorectal cancer (CRC) is the third most common cancer and third leading cause of cancer death in the United States. 1 Given advances in early detection and treatment, the number of CRC survivors is estimated to exceed 1.4 million in 2016 and expected to grow over the coming decades. 2 Many cancer survivors are motivated to seek self-care strategies, particularly dietary counseling, to facilitate their treatment and recovery. 3 However, due to lack of data on postdiagnostic diet and CRC survival, most dietary recommendations for CRC survivors are primarily based on incidence studies. 4, 5 Therefore, identifying prognostic dietary factors is needed to improve CRC survivorship. Fiber has been associated with lower risk of CRC in manybut not all-studies. 6 The most recent expert report concludes that consumption of foods containing dietary fiber probably protects against CRC. 7 Fiber helps to minimize exposure to intestinal carcinogens by diluting fecal content and decreasing transit time 8 and also has systemic benefits on insulin sensitivity and metabolic regulation, 9 which have been linked to CRC prognosis. 10 Moreover, fiber can be fermented by the gut bacteria into short-chain fatty acids, such as butyrate, acetate, and propionate, that possess a diversity of tumorsuppressive effects. 11, 12 Preclinical studies have indicated the potential of butyrate and its analogs as chemotherapeutic agents in several tumor models, 13,14 including CRC.
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Despite these data, to our knowledge, no study has yet examined the association between fiber intake and survival of patients with CRC. Therefore, we used data from 2 large prospective cohorts-the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS)-to test the hypothesis that high consumption of fiber and its major food sources after CRC diagnosis might be associated with lower mortality.
Methods

Study Population
The NHS enrolled 121 700 US registered female nurses who were aged 30 to 55 years in 1976. The HPFS enrolled 51 529 US male health care professionals who were aged 40 to 75 years in 1986. Details about the 2 cohorts have been described elsewhere. 16, 17 Briefly, participants were mailed a questionnaire inquiring about their medical history and lifestyle factors at baseline and every 2 years thereafter. Dietary data were collected and updated every 4 years using food frequency questionnaires (FFQs). In the present analysis, we used 1980 for the NHS and 1986 for the HPFS as baseline when we first collected detailed data on fiber intake. The follow-up rates have been 95.4% in the NHS and 95.9% in the HPFS for each of the questionnaires through 2010. The present study was conducted from December 23, 2016, to August 23, 2017. This study was approved by the institutional review board at the Brigham and Women's Hospital. We obtained written informed consent from all participants.
Ascertainment of CRC Cases
On each biennial follow-up questionnaire, participants were asked whether they had received a diagnosis of CRC during the previous 2 years. For participants who reported CRC diagnosis, we asked for their written informed consent to acquire medical records and reports of pathologic tests. Study physicians, blinded to exposure data, reviewed all medical records to confirm CRC diagnosis and record the disease stage, histologic findings, and tumor location. 18 In the present analysis,
we included a total of 1575 participants who were diagnosed with stage I to III CRC throughout follow-up and completed the FFQ after diagnosis (963 in the NHS and 612 in the HPFS) (eFigure in the Supplement).
Ascertainment of Deaths
Deaths were identified through review of the National Death Index, family members, or the postal system in response to the follow-up questionnaires. The cause of death was assigned by study physicians based on all available data, including medical records. More than 96% of the deaths have been identified using these methods.
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Assessment of Fiber Intake
Dietary intake data were collected repeatedly by FFQs in which participants were asked how often, on average, they consumed each food of a standard portion size during the previous year. We calculated the daily intake for each nutrient by multiplying the reported frequency of consumption of each item by its nutrient content and then summing across all foods. Fiber intake was calculated using the Association of Official Analytical Chemists method (accepted by the US Food and Drug Administration and the Food and Agriculture Organization of the World Health Organization for nutrition labeling purposes). 20 We adjusted fiber intake for total caloric intake using the nutrient residual method. 21 Food frequency questionnaires have shown good reproducibility and validity for assessing fiber intake (eMethods in the Supplement).
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Fiber intake from major food sources, including cereals, vegetables, and fruits, was considered separately. We also assessed whole grain consumption from all grain-containing foods (rice, bread, pasta, and breakfast cereals) according to the dry weight of whole grain ingredients in each food, as previously described. 23 For postdiagnostic intake, the first FFQ collected at least 6 months but no more than 4 years after diagnosis (median, 2.2 years) was used to avoid assessment during the period of active treatment. 24 In a sensitivity analysis, we also examined the cumulative mean intake of fiber throughout the entire postdiagnostic period (eMethods in the Supplement). Prediagnostic intake was based on the last FFQ reported before CRC diagnosis.
Statistical Analysis
We calculated person-time of follow-up from the return date of the FFQ that was used for postdiagnostic assessment to death or the end of the study period (June 1, 2012, for the NHS and January 31, 2012, for the HPFS), whichever came first. In the main analysis, death from CRC was the primary end point, and deaths from other causes were censored. In secondary analyses, death from any cause was the end point. We used cause-specific Cox proportional hazards regression models with time since diagnosis as the time scale, accounting for left truncation due to differences between patients in the timing of postdiagnostic assessment. 25 We calculated hazard ratios (HRs) and 95% CIs of death, adjusted for prediagnostic fiber intake and other potential predictors for cancer survival (eMethods in the Supplement). The Wald test for trend was performed using the median for each quartile of fiber intake as a continuous variable. We tested proportional hazards assumption by including the interaction term between fiber intake and time into the model and did not find statistical evidence for violation of this assumption.
To reduce residual confounding, we further adjusted for a propensity score that reflected associations of fiber consumption with potential confounding covariates. 26 To minimize any bias resulting from the availability of postdiagnostic questionnaire data, we applied the inverse probability weighting method to all survival analyses. 27 We examined the dose-response relationship between fiber intake and mortality using the restricted cubic spline analysis. 28 More details about these analyses are provided in the eMethods in the Supplement. We also calculated the change in fiber intake by subtracting the prediagnostic intake from the postdiagnostic intake and examined the association with mortality. Moreover, we assessed consumption of whole grains and different sources of fiber. Finally, we conducted the stratified analysis by clinicopathologic and lifestyle factors. P value for interaction was calculated using the likelihood ratio test. All statistical tests were 2-sided, and P < .05 was considered statistically significant. We used SAS, version 9.4 for all analyses (SAS Institute).
Results
Basic Characteristics of Participants
Among 1575 eligible patients diagnosed with stage I to III CRC, 963 (61.1%) were women; mean (SD) age was 68.6 (8.9) years. We documented 773 deaths, of which 174 (22.5%) were classified as CRC-specific deaths over a median of 8 years of followup. Other major causes of death included cardiovascular diseases (n = 168) and cancers other than CRC (n = 121). The overall 5-year survival rates were 83% (95% CI, 79%-86%) for stage I cancer, 82% (95% CI, 78%-86%) for stage II cancer, and 72% (95% CI, 67%-76%) for stage III cancer. These rates appeared to be comparable to national estimates. 29 Participants with higher fiber intake tended to have a healthier lifestyle (eTable 1 in the Supplement). Anatomic subsite and grade of differentiation did not differ across quartiles of fiber intake, whereas patients with the highest fiber intake were more likely to have stage I cancer than stage II and III cancers. To stringently control for any confounding effect by stage, we performed stage-stratified Cox regression for all the association analyses.
Total Fiber Intake After Diagnosis and Survival
As reported in Table 1 , fiber intake was inversely associated with CRC-specific mortality after adjusting for other potential determinants for cancer prognosis. The multivariable HR per each 5-g increase in intake per day was 0.78 (95% CI, 0.65-0.93; P = .006) for CRC-specific mortality and 0.86 (95% CI, 0.79-0.93; P < .001) for all-cause mortality. Similar findings were obtained when cumulative mean fiber consumption after diagnosis was used for the analysis (eTable 2 in the Supplement).
The spline analysis showed a linear relationship between fiber intake after diagnosis and CRC-specific mortality. For allcause mortality, a statistically significant nonlinear relationship was observed. The benefit associated with increasing fiber intake achieved its maximum at approximately 24 g/d, and no further reduction in mortality was found beyond this level of intake ( Figure) .
To minimize bias associated with occult recurrences or other undiagnosed major illnesses that could influence dietary intake, we excluded the first year of follow-up in a sensitivity analysis. The results remained essentially unchanged, with the multivariable HR per 5-g/d increment for CRC-specific mortality of 0.80 (95% CI, 0.66-0.97; P = .02 for trend) and the HR for all-cause mortality of 0.85 (95% CI, 0.78-0.93; P = .002 for trend). Similar results were also obtained in the propensity score analysis, with the corresponding HRs of 0.80 (95% CI, 0.67-0.96; P = .02 for trend) and 0.86 (95% CI, 0.79-0.93; P < .001 for trend), respectively, indicating the robustness of our findings to confounding.
No statistically significant interaction was detected between fiber intake and tumor subsite or stage (P > .05 for interaction) (eTable 3 in the Supplement). In a subset of patients with chemotherapy data (n = 375), fiber intake was similar among those who received chemotherapy (median, 19.5 g/d) and those who did not (median, 19.1 g/d) (P = .13 for Wilcoxon test).
Change in Total Fiber Intake After Diagnosis and Survival
Prediagnostic and postdiagnostic intake of fiber were modestly correlated (Spearman correlation coefficient r = 0.58). We assessed whether changing fiber intake after diagnosis was associated with mortality. As reported in Table 2 , patients who increased their fiber intake after diagnosis from levels before diagnosis had a lower mortality rate, and each 5-g/d increase in fiber intake was associated with 18% lower CRC-specific mortality (95% CI, 7%-28%; P = .002) and 14% lower all-cause mortality (95% CI, 8%-19%; P < .001).
Fiber Intake of Different Food Sources and Survival
Next, we examined associations by major dietary sources of fiber, including those from cereals, vegetables, and fruits. Fiber intakes from these sources were weakly correlated (Spearman correlation coefficient r<0.25) (eTable 4 in the Supplement). As noted in Table 3 , fiber from cereals showed an inverse association with lower mortality after mutual adjustment for fruit and vegetable fiber. The HR associated with 5-g/d increments in cereal fiber was 0.67 (95% CI, 0.50-0.90; P = .007 for trend) for CRC-specific mortality and 0.78 (95% CI, 0.68-0.90; P < .001 for trend) for all-cause mortality. In contrast, no association was found for fruit fiber. Vegetable fiber was as- Colorectal cancer-specific mortality (A) and all-cause mortality (B) shown. Dashed lines represent the 95% CIs of the hazard ratio (HR). Multivariable model was adjusted for the same set of covariates as in Table 1 . For colorectal cancer-specific mortality, no spline variable was selected and P = .004 for linearity; for all-cause mortality, there was a nonlinear relationship with P = .007 for nonlinearity and P < .001 for the overall significance. The number of patients appears in the middle of each interval because it represents the number of patients whose fiber consumption lies within each interval. Patients at risk are those within each interval of fiber intake (containing the lower limit but not the upper limit of fiber intake). 
Whole Grain Intake After Diagnosis and Survival
Whole grain consumption was associated with lower CRCspecific mortality, with the multivariable HR per 20-g/d increment of 0.72 (95% CI, 0.59-0.88; P = .002 for trend) ( Table 4) . This association was attenuated after adjusting for total fiber intake (HR, 0.77; 95% CI, 0.62-0.96; P =. 02for trend). Similar, but weaker, attenuation was observed for allcause mortality, with the HR changing from 0.88 (95% CI, 0.80-0.97; P = .008 for trend) to 0.91 (95% CI, 0.83-1.01; P = .08 for trend) after including fiber in the multivariable model.
Fiber Intake and Survival Within Subgroups
In an exploratory analysis, we examined whether the association between total fiber intake and mortality differed by other predictors of cancer prognosis, including sex, age, smoking status, alcohol consumption, body mass index, physical activity, aspirin use, and dietary glycemic load (eTable 5 in the Supplement). We observed a statistically significant interaction with alcohol consumption for CRC-specific mortality (for patients with alcohol intake <7 g/day: HR, 0.73; 95% CI, 0.57-0.94; for patients with alcohol intake ≥7 g/day: HR, 1.07; 95% CI, 0.75-1.52; P = .05) and with regular aspirin use for allcause mortality (for patients who did not regularly use aspirin: HR, 0.81; 95% CI, 0.73-0.91; for regular aspirin users: HR, 0.99; 95% CI, 0.86-1.13; P = .01). However, given the multiple testing and limited event numbers, these findings should be interpreted cautiously. No other statistically significant interaction was detected.
Discussion
To our knowledge, this is the first prospective study examining the prognostic influence of fiber intake among patients with CRC. We found that patients with a higher intake of fiber, especially that from cereals, had a lower rate of CRC-specific and all-cause mortality. Patients who increased their intake from their levels before diagnosis experienced a modest reduction in mortality. Higher consumption of whole grains was also associated with better survival, and this beneficial association was partly mediated by fiber. Our findings provide novel evidence for the potential benefit of increasing fiber and whole grain consumption among patients with CRC. Substantial evidence supports the protective effect of high fiber intake for CRC prevention. According to a meta-analysis of 25 prospective studies, each 10-g increment in daily intake of total and cereal fiber was associated with an approximately 10% lowered risk of developing CRC. 30 This finding agrees with the well-established data from animal studies that high-fiber diets promote apoptosis and suppress colorectal tumor development. [31] [32] [33] Our present study adds to the existing literature and suggests that the effect of high fiber intake may extend beyond protection against cancer incidence and contribute to better prognosis after cancer is established. Higher intake of fiber, especially cereal fiber, has been linked to improved insulin sensitivity, 34 lipid profile, 35 endothelial function, and reduced inflammation. 36 Emerging, albeit limited, evidence suggests that hyperinsulinemia and markers of insulin resistance and inflammation predict worse survival in patients with CRC 37,38 and may mediate the adverse metabolic effect of obesity and physical inactivity on CRC recurrence and death. 24, 39 Therefore, higher fiber intake after CRC diagnosis may improve patients' survival by mitigating the tumor-promoting effect of hyperinsulinemia and inflammation. .29
Abbreviations: HR, hazard ratio; IQR, interquartile range.
a Postdiagnostic intake was assessed at least 6 months but no more than 4 years after diagnosis to minimize the influence of active treatment.
b Cox proportional hazards regression model stratified by age groups at diagnosis (<60, 60-64, 65-69, 70-74, and Ն75 years), sex, and cancer stage (I, II, III, and unspecified), with additional adjustment for age at diagnosis (continuous). 
Research Original Investigation Fiber Intake and Colorectal Cancer Survival
Bacterial fermentation of fiber also produces butyrate, which has been increasingly implicated in modulation of the tumor microenvironment.
12 Although butyrate is a major energy source for normal colonocytes, it is metabolized to a lesser extent in cancer cells due to the Warburg effect and accumulates in the nucleus of cancerous colonocytes in which it functions as an inhibitor of histone deacetylase to epigenetically regulate expression of numerous genes responsible for tumor growth, angiogenesis, migration, and chemoresistance. Consistent with these data, we found that patients with CRC who consumed higher levels of fiber after diagnosis had substantially lower rates of death. The beneficial association appeared to differ by fiber sources, with cereal fiber showing the strongest association. These findings are further supported by the favorable survival rates in association with high consumption of whole grain, a rich source of cereal fiber. Concordant with our findings, previous studies support the importance of fiber sources. Compared with fiber from other sources, cereal fiber and whole grains have been most consistently associated with a lower incidence of colorectal neoplasia, 30,45-48 type 2 diabetes, 49,50 cardiovascular disease, 50,51 and total mortality. 50,52 Although the exact reasons remain unclear, it is possible that the generally high fiber content of cereals, especially whole grains, may contribute to the more pronounced benefit, whereas the amount of fiber consumed from fruits may be too low for an association with health outcomes to be observed. Alternatively, other components in cereals and whole grains may contribute to their favorable effects, such as vitamins, minerals, phenols, and phytoestrogens. [53] [54] [55] However, in the present study, adjusting for fiber intake attenuated the association between whole grain and lower mortality, suggesting that fiber may be an important contributor for the protective effect of whole grains.
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Strengths and Limitations
Advantages of the present study include the prospective design, detailed collection of prediagnostic and postdiagnostic diet and lifestyle information, standardized medical record review of self-reported CRC and deaths, and long-term followup. Moreover, the detailed covariate data collected in parallel with fiber intake allowed for rigorous control for confounding by various predictors of cancer survival. There are limitations that are worth noting. First, detailed treatment data were largely unavailable in the cohorts. However, among a subset of patients with chemotherapy data, fiber intake did not differ by the use of chemotherapy. Moreover, during the time of the study, adjuvant treatment was largely standardized and primarily correlated with disease stage. Thus, our ability to control for stage in our analyses minimized any potential confounding by treatment. In addition, because all participants were health care professionals, any difference in access to adjuvant chemotherapy is minimized. Second, beyond cause of mortality, data on cancer recurrences were unavailable in our cohorts. Nevertheless, because the median survival for metastatic CRC was approximately 10 to 12 months during much of this study, 57 CRC-specific mortality should be a reasonable surrogate for cancer-specific outcomes. Third, the number of CRC-specific deaths is relatively small; therefore, further large-scale studies are needed. Finally, as an observational study, residual confounding cannot be excluded, although we observed similar results 
Conclusions
Higher intake of fiber and whole grains after CRC diagnosis is associated with a lower rate of death from that disease and other causes. Our findings provide support for the nutritional recommendations of maintaining sufficient fiber intake among CRC survivors. 
Covariate assessments
To control for confounding, we adjusted for a variety of covariates in the multivariable regression model. These covariates can be grouped into the following four categories:
demographic characteristics (age at diagnosis, sex, year of diagnosis), clinicopathological factors (tumor stage, anatomic subsite, and differentiation), lifestyle factors (body mass index, physical activity, alcohol consumption, aspirin use), and dietary factors (vitamin D, total fat, folate, calcium, and glycemic load).
Data on tumor stage, histology, and anatomic location (proximal colon, distal colon, and rectum)
were extracted from medical records by study physicians. Proximal colon cancers were defined as those from the cecum to and including the splenic flexure, and distal colon cancers were defined as those in the descending and sigmoid colon. Family history was defined based on the diagnosis of CRC among any of parents or siblings of study participants. We assessed the postdiagnostic intakes of macronutrients, alcohol, folate, calcium and vitamin D based on the FFQs.
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Dietary glycemic load was calculated to quantify the influence of carbohydrate intake on blood glucose. 2 We collected updated data on body mass index, smoking status, and regular use of aspirin from the biennial questionnaires. Leisure-time physical activity was assessed using the validated questionnaire in 1980, 1982, 1986, 1988, 1992 , and biennially thereafter in the NHS;
and every two years in the HPFS, by summing the products of time spent on a variety of activities with the mean metabolic equivalent (MET) for that activity.
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Assessment of chemotherapy use
We assessed chemotherapy use through a supplemental questionnaire in a subset of colorectal cancer patients included in the analysis from the Nurses' Health Study (n=375). Participants were asked whether they had been treated with any of the chemotherapeutic agents that were 
Statistical analysis
Sensitivity analysis for cumulative average intake after diagnosis
In a sensitivity analysis, we examined the cumulative average intake of fiber throughout the entire post-diagnostic period, which was calculated as a time-varying variable by the mean fiber intake from the first questionnaire returned immediately after diagnosis up to the questionnaire prior to the current follow-up cycle. The assessment period was up to the last questionnaire before patients' death for those who were dead during follow-up, and up to the end of the study (June 1, 2012 for the NHS cohort and January 31, 2012 for the HPFS cohort) for those who did not die through the end of the study (i.e., censored).
Propensity score analysis
In addition to multivariable adjustment, we performed the propensity score analysis to further control for potential confounding by clinicopathological and diet/lifestyle factors. We estimated the predicted probability (propensity score) of consuming high amount of fiber after diagnosis in each participant using a logistic regression that included all the variables in our multivariable model. 4, 5 These variables are both important predictors for cancer prognosis and correlates of post-diagnostic fiber intake in our study population (as shown in eTable 1). They can be grouped into the following four categories: demographic characteristics (age at diagnosis, sex), clinicopathological factors (tumor stage, subsite, differentiation, and year of diagnosis), lifestyle factors (body mass index, physical activity, alcohol consumption, aspirin use), and dietary factors (vitamin D, total fat, folate, calcium, and glycemic load). In addition, we also included the 45 pairwise interaction terms between the continuous variables into the model. 6 We then adjusted for the propensity score to examine the association of fiber intake after diagnosis with CRC-specific and all-cause mortality.
Inverse probability weighting (IPW) analysis
Because patients included in the current study represent a subset of CRC patients diagnosed in the two cohorts who returned their dietary questionnaire within the window of 6 months to 4 years after diagnosis, to minimize any bias resulting from the availability of post-diagnostic questionnaire data, we applied the IPW method to the survival analyses, as previously described. [7] [8] [9] The probability of questionnaire return after diagnosis was estimated using the 
Restricted cubic spline analysis
We examined the dose-response relationship between fiber intake and mortality using the restricted cubic spline analysis. 10 Three knots corresponding to the 5%, 50%, and 95%
percentiles of post-diagnostic fiber intake were used. An automatic stepwise procedure was used to select spline variables according to the P<0.05 for both inclusion and retention in the model, and a likelihood ratio test was used to assess the non-linearity by comparing the model with only the linear term to the model with both the linear and cubic spline terms. The overall significance was also assessed via a likelihood ratio test by comparing the model with and without fiber intake. No spline variable was selected into the model for the analysis of total fiber intake in relation to CRC-specific mortality, whereas one spline variable entered into the final model for all-cause mortality analysis. Based on the spline models, we calculated and plotted the hazard ratios of mortality for continuous increment in total fiber intake using the lowest intake level as the reference value (Figure 1) . 
